Haloperidol and sudden cardiac death in dementia: Autopsy findings in psychiatric inpatients

International Journal of Geriatric Psychiatry

Volumn 30, Issue 12, 2015, Pages 1224-1229

  Ifteni, Petru ^a   Grudnikoff, Eugene ^b   Koppel, Jeremy ^c,d,e   Kremen, Neil ^b,c   Correll, Christoph U ^b,c,e,f   Kane, John M ^b,c,e,f   Manu, Peter ^b,c,f  

^a TRANSILVANIA UNIVERSITY OF BRASOV   (Romania)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^d Litwin Zucker Research Center for the Study of Alzheimer's Disease and Memory Disorders   (United States)

^e FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Death; Dementia; Haloperidol; Unexpected

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT;

AGED; AIRWAY OBSTRUCTION; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; MYOCARDITIS; PNEUMONIA; SUDDEN CARDIAC DEATH; UPPER GASTROINTESTINAL BLEEDING; DEATH, SUDDEN, CARDIAC; DEMENTIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; AUTOPSY; DEATH, SUDDEN, CARDIAC; DEMENTIA; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 84947032966     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4277     Document Type: Article

References (31)

1. Andreasen NC, Pressler M, Nopoulos P, et al., 2010. Antipsychotic dose equivalents and dose-years: A standardized method for comparing exposure to different drugs. Biol Psychiatry 67: 255-262.
2. Aronow WS,. 2000. Clinical causes of death of 2372 older persons in a nursing home during 15-year follow up. J Am Med Dir Assoc 1: 95-96.
3. Barak Y, Baruch Y, Mazeh D, Paleacu D, Aizenberg D,. 2007. Cardiac and cerebrovascular morbidity and mortality associated with antipsychotic medications in elderly psychiatric inpatients. Am J Geriatr Psychiatry 15: 354-356.
4. Batty GD, Russ TC, Starr JM, et al., 2014. Modifiable cardiovascular disease risk factors as predictors of dementia death; pooling of ten general population-based cohort studies. J Negat Results Biomed 13: 8.
5. Behr ER, Casey A, Sheppard M, et al., 2007. Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death. Heart 93 (5): 601-605.
6. Coady SA, Sorlie PD, Cooper LS, et al., 2001. Validation of death certificate diagnosis for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Clin Epidemiol 54 (1): 40-50.
7. Every NR, Parsons L, Hiatky MA, et al,. 1997. Use and accuracy of state death certificates for classification of sudden cardiac deaths in high-risk populations. Am Heart J 134 (6): 1129-1132.
8. Food and Drug Administration. 2008. http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm123214.htm (accessed October 24, 2014).
9. Gerhard T, Huybrechts K, Olfson M, et al., 2014. Comparative mortality risks of antipsychotic medications in community-dwelling older adults. BJ Psych 205: 44-51. DOI: 10.1192/bjp.bp.112.122499.
10. Goraya TY, Jacobsen SJ, Belau PG, et al., 2000. Validation of death certificate diagnosis of out-of-hospital coronary heart disease deaths in Olmstead County, Minnesota. Mayo Clin Proc 75 (7): 981-687.
11. Hales HC, Valenstein M, Kim HM, et al., 2007. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry 164 (10): 1568-1576.
12. Hassaballa HA, Balk RA,. 2003. Torsade de pointes associated with the adminsitartion of intravenous haloperidol: a review of the literature and practical guideline for use. Expert Opin Drug Saf 2: 543-547.
13. Hicks KL, Black BS, Rabins P., 2010. Predictors of mortality in nursing home residents with advanced dementia. Am J Alzheimers Dis Other Dem 25: 439-445.
14. Iribarren C, Crow RS, Hannan PJ, Jacobs DR, Luepker RV,. 1998. Validation of death certificate diagnosis of out-of-hospital sudden cardiac death. Am J Cardiol 82 (1): 50-53.
15. Kales HC, Kim HM, Zivin K, et al., 2012. Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry 169 (1): 71-79. DOI: 10.1176/appi.ajp.2011.11030347.
16. Liperoti R, Onder G, Landi F, et al., 2009. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. J Clin Psychiatry 70 (10): 1340-1347. DOI: 10.4088/JCP.08m04597yel.
17. Lopez OL, Becker JT, Chang YF, et al,. 2013. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry 170 (9): 1051-1058. DOI: 10.1176/appi.ajp.2013.12081046.
18. Manu P, Kane JM, Correll CU,. 2011. Sudden deaths in psychiatric patients. J Clin Psychiatry 72 (7): 936-941. DOI: 10.4088/JCP.10m06244gry.
19. Mewton N, Liu CY, Croisille P, Bluemke D, Lima J,. 2011. Assessment of myocardial fibrosis with cardiac magnetic resonance. J Am Coll Cardiol 57: 891-903.
20. Ray WA, Meredith S, Thapa PB, et al,. 2001. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 58 (12): 1161-1167.
21. Ray WA, Chung CP, Murray KT, et al,. 2009. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360 (3): 225-235.
22. Salib E, Tadros G, Ambrose A,. 2000. Autopsy in elderly psychiatric inpatients: a retrospective review of autopsy findings of deceased elderly psychiatric inpatients in North Chesire 1980-1996. Med Sci Law 40 (1): 20-27.
23. Scarmeas N, Brandt J, Albert M, et al,. 2005. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol 62 (10): 1601-1608.
24. Schindler JS, Kelly JH,. 2002. Swallowing disorders in the elderly. Laryngoscope 112: 589-602.
25. Schneider LS, Dagerman KS, Insel P,. 2005. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294 (15): 1934-1943.
26. Steinberg M, Lyketsos CG,. 2012. Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatry 169 (9): 900-906. DOI: 10.1176/appi.ajp2012.12030342.
27. Todd S, Barr S, Roberts M, et al,. 2013. Survival in dementia and predictors of mortality: a review. Int J Geriatric Psychiatry 28 (11): 1109-1124.
28. Trifiro G, Verhame KM, Ziere G, et al., 2007. All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepedemiol Drug Saf 16 (5): 538-544.
29. Trifiro G, Gambassi G, Sen EF, et al., 2010. Association of community-acquired pneumonia with antipsychotic drug use in the elderly. Ann Intern Med 152: 418-425.
30. Trifiro G, Sultana J, Spina E,. 2014. Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies. Drug Saf 37 (7): 501-520. DOI: 10.1007/s40264-014-0170-y.
31. Vilalta-Franch J, Lopez-Pousa S, Calvo-Perxas L, Garre-Olmo J,. 2013. Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality. Am J Geriatr Psychiatry 21 (11): 1135-1143. DOI: 10.1016/j.jagp.2013.01.051.